Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
CHICAGO, IL--(Marketwire - Nov 13, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the 12-month results of the...
-
CHICAGO, IL--(Marketwire - Nov 12, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, today announced the commercial...
-
CHICAGO, IL--(Marketwire - Apr 21, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced that the CyPass...